These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29722608)

  • 1. Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?
    Whelan A; Johnson MI
    Pain Manag; 2018 May; 8(3):217-229. PubMed ID: 29722608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain.
    Van Der Walt J; Parker R
    S Afr Med J; 2023 Nov; 113(11):22-26. PubMed ID: 38525640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.
    Le GH; Wong S; Badulescu S; Au H; Di Vincenzo JD; Gill H; Phan L; Rhee TG; Ho R; Teopiz KM; Kwan ATH; Rosenblat JD; Mansur RB; McIntyre RS
    J Affect Disord; 2024 Jun; 355():342-354. PubMed ID: 38570038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits.
    Videira NB; Nair V; Paquet V; Calhoun D
    J Appl Toxicol; 2024 Feb; 44(2):216-234. PubMed ID: 37646119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia.
    Darke S; Duflou J; Peacock A; Farrell M; Hall W; Lappin J
    Addiction; 2024 May; ():. PubMed ID: 38771189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular safety of psychedelic medicine: current status and future directions.
    Wsół A
    Pharmacol Rep; 2023 Dec; 75(6):1362-1380. PubMed ID: 37874530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review.
    Więckiewicz G; Stokłosa I; Piegza M; Gorczyca P; Pudlo R
    Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review.
    Pouyan N; Younesi Sisi F; Kargar A; Scheidegger M; McIntyre RS; Morrow JD
    CNS Drugs; 2023 Dec; 37(12):1027-1063. PubMed ID: 37999867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adapting psychedelic medicine for headache and chronic pain disorders.
    Schindler EAD; Hendricks PS
    Expert Rev Neurother; 2023; 23(10):867-882. PubMed ID: 37652000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.
    Ko K; Kopra EI; Cleare AJ; Rucker JJ
    J Affect Disord; 2023 Feb; 322():194-204. PubMed ID: 36209780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.
    Dos Santos RG; Osório FL; Crippa JA; Riba J; Zuardi AW; Hallak JE
    Ther Adv Psychopharmacol; 2016 Jun; 6(3):193-213. PubMed ID: 27354908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD).
    Beutler BD; Shinozuka K; Tabaac BJ; Arenas A; Cherian K; Evans VD; Fasano C; Muir OS
    Am J Ther; 2024 Mar-Apr 01; 31(2):e104-e111. PubMed ID: 38518267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin 5-HT
    McIntyre RS
    Expert Opin Drug Saf; 2023; 22(10):881-883. PubMed ID: 37581427
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases.
    Gasser P; Holstein D; Michel Y; Doblin R; Yazar-Klosinski B; Passie T; Brenneisen R
    J Nerv Ment Dis; 2014 Jul; 202(7):513-20. PubMed ID: 24594678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences.
    Zeifman RJ; Kettner H; Pagni BA; Mallard A; Roberts DE; Erritzoe D; Ross S; Carhart-Harris RL
    Sci Rep; 2023 Aug; 13(1):13645. PubMed ID: 37608057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021.
    Keyes KM; Patrick ME
    Addiction; 2023 Dec; 118(12):2449-2454. PubMed ID: 37287110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magic of the Mushrooms: Effects of Psilocybin Decriminalization.
    Bhave A
    J Psychoactive Drugs; 2024 Jul; ():1-10. PubMed ID: 38984875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Lysergic Acid Diethylamide by Major Depression Status.
    Walsh CA; Gorfinkel L; Shmulewitz D; Stohl M; Hasin DS
    JAMA Psychiatry; 2024 Jan; 81(1):89-96. PubMed ID: 37819655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.
    O'Donnell KC; Anderson BT; Barrett FS; Bogenschutz MP; Grob CS; Hendricks PS; Kelmendi B; Nayak SM; Nicholas CR; Paleos CA; Stauffer CS; Gukasyan N
    Am J Psychiatry; 2024 Jan; 181(1):74-75. PubMed ID: 38161295
    [No Abstract]   [Full Text] [Related]  

  • 20. Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.
    Rootman JM; Kryskow P; Harvey K; Stamets P; Santos-Brault E; Kuypers KPC; Polito V; Bourzat F; Walsh Z
    Sci Rep; 2021 Nov; 11(1):22479. PubMed ID: 34795334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.